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hildren and adolescents diagnosed with a bipo-
lar (BP) disorder face substantial obstacles.Besides the
human suffering associated with the mood symptoma-
tology which they experience, greater academic prob-
lems,difficulties with peers,and high levels of family dys-
function are often found in youths with bipolar
disorder.
1,2 Furthermore,children and adolescents with
bipolar disorder have an increased risk of substance use,
suicidal ideation, suicide attempts, and completed sui-
cide.
3,4 In fact,Goldstein et al
5 found that approximately
32% of 405 youths under the age of 18 with a bipolar
spectrum disorder reported having a previous serious sui-
cide attempt. In the hope of reducing the substantive
sequelae associated with this condition, research has
begun to examine how best to recognize early-onset
bipolar disorder in children and effectively treat these
patients earlier in their course of illness.
Prevalence of bipolar disorder 
The lifetime prevalence of a bipolar spectrum disorder in
adults has been estimated to be approximately 4.5%,with
subsyndromal bipolar disorders being more prevalent
(2.4%) than Bipolar I Disorder (BP-I) or Bipolar II
Disorder (BP-II).
6 Epidemiological studies have found
bipolar spectrum disorders to be present in approximately
0.1% to 1% of children and adolescents (see ref 7 for
review). Recently it has been noted that the number of
office visits for youth with bipolar disorder has increased
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Although recently more research has considered children
with bipolar disorder than in the past, much controversy
still surrounds the validity of the diagnosis. Furthermore,
questions remain as to whether or not childhood expres-
sions of bipolarity are continuous with adult manifesta-
tions of the illness. In order to advance current knowl-
edge of bipolar disorders in children, researchers have
begun to conduct phenomenological, longitudinal,
treatment, and neuroimaging studies in youths who
exhibit symptoms of bipolar illness, as well as offspring
of parents with bipolar disorders. Regardless of the dif-
ferences between research groups regarding how bipo-
lar disorder in children is defined, it is agreed that pedi-
atric bipolarity is a serious and pernicious illness. With
early intervention during the period of time in which
youths are exhibiting subsyndromal symptoms of pedi-
atric bipolarity, it appears that the progression of the ill-
ness to the more malignant manifestation of the disor-
der may be avoided. This paper will review what is
currently known and what still is left to learn about clin-
ically salient topics that pertain to bipolar disorder in
children and adolescents.    
© 2008, LLS SAS Dialogues Clin Neurosci. 2008;10:215-228.40-fold over the past 10 years,indicating that either this
syndrome was under-recognized in the past,or that chil-
dren are now being diagnosed incorrectly.
8As will be dis-
cussed later, there is substantial symptom overlap that
exists between bipolar spectrum disorders and other psy-
chiatric conditions.In fact,it is possible that it is this symp-
tom overlap that may account for the differences between
the past and present rates at which the diagnosis of bipo-
larity is given to children and adolescents.
Phenomenology
Phenomenology studies have begun to explore the symp-
tom presentation of bipolar disorder throughout early
childhood,adolescence,and into adulthood.
9-12As a result
of current research,there is a growing body of evidence
to support the assertion that elevated mood may be a key
symptom in pediatric BP spectrum disorders,which dis-
tinguishes this condition from other psychiatric illnesses.
13
For example,Axelson et al
4 found that approximately
82% of youths with bipolar disorder not otherwise spec-
ified (BP-NOS) and 92% of children and adolescents
with BP-I reported elevated mood. Furthermore,
Findling et al
14 found that elevated mood was the best
predictor of BP-NOS or cyclothymic disorder in off-
spring of a parent with bipolar disorder.
Although elevated mood is a distinguishing symptom in
pediatric bipolarity,youths with bipolar disorders have
been shown to exhibit substantive rates of aggression and
irritability.
13,15,16 For instance,Danielyan et al
9 found that
88.5% of their sample reported aggression and 84.6%
reported irritability. However, it should be noted that
symptoms of aggression and irritability,although promi-
nent in pediatric bipolarity,are symptoms of many other
childhood psychiatric disorders such as disruptive behav-
ior disorders and depression.Therefore,due to their lack
of diagnostic specificity,irritability and aggression may
not be the best means by which to differentiate pediatric
bipolar illness from other psychiatric conditions in the
young.
Other common symptoms observed in children and ado-
lescents with bipolar illness across multiple pediatric
studies include other diagnostic symptom criteria for
mania described in the DSM-IV
17:increased energy,dis-
tractibility, pressured speech, grandiosity, and racing
thoughts (see ref 13 for review).
Notably,it appears that most children and adolescents
meet DSM-IV criteria for BP-NOS rather than the symp-
tomatic manifestations of BP-I or BP-II.
12Additionally,
it appears that the most common reason that children
and adolescents meet DSM-IV criteria for BP-NOS but
do not meet criteria for BP-I or BP-II is not due to lack
of meeting an adequate number of symptom criteria,but
rather failing to meet episode duration criteria.
4
However,despite the fact that subjects do not meet full
DSM-IV criteria for BPI or BP-II,patients with BP-NOS
and cyclothymic disorder also suffer from impairing
mood symptoms.
4,14 In short,although the rates at which
symptoms are reported in pediatric bipolar illness appear
to vary somewhat across research sites, it is clear that
there is a group of children and adolescents who present
with symptoms of bipolar spectrum disorders as defined
by DSM-IV criteria.
17
Comorbidity 
In addition to mood episodes and their associated symp-
toms,adults and children with bipolar disorder also have
been reported to experience high rates of comorbid psy-
chiatric diagnoses.In a nationally representative sample
of adults,over 90% of respondents with a bipolar spec-
trum disorder reported at least one comorbid diagnosis.
6
The most frequent comorbid diagnoses found in adults
with bipolar disorder in this study were anxiety disorders.
Similarly to adults,high rates of comorbid diagnoses have
been found in children and adolescents with bipolar dis-
orders. For example, Tillman et al
18 found that almost
98% of 91 children and adolescents with a bipolar spec-
trum disorder examined also suffered from a comorbid
psychiatric disorder.Kowatch et al
13 reported in a meta-
analysis that attention deficit-hyperactivity disorder
(ADHD) was the most frequent comorbid diagnosis in
children and adolescents with bipolar disorder. Other
common comorbid diagnoses in youth with bipolar dis-
order include oppositional defiant disorder (ODD),anx-
iety disorders,conduct disorder (CD),and substance use
disorders.
13 Rates of comorbid psychiatric diagnoses
reported in youth with bipolar disorders vary from 11%
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Selected abbreviations and acronyms
ADHD attention deficit–hyperactivity disorder
BPD bipolar disorder
BP-NOS bipolar disorder not otherwise specified
CBT cognitive behavior therapy
DVPX divalproex
IPSRT interpersonal and social rhythm therapyto 90% presenting with ADHD,46% to 75% with ODD,
5% to 37% with CD,12% to 77% with anxiety disorders,
and up to 40% of adolescents with a substance use dis-
order.
4,10,12,19-24 One possible explanation for the varying
and high rates of reported comorbid diagnoses in youths
with a bipolar spectrum disorder may be the result of
overlapping symptoms across diagnoses that may be
attributable to other disorders.For example,inattention,
distractibility, impulsivity, psychomotor agitation, and
sleep disturbances can be characteristic of both children
and adolescents with bipolar disorder as well as ADHD.
25
As noted above,irritability and aggression are common
symptoms observed in adolescents with bipolar disorder.
However,these symptoms are also characteristic of a dis-
ruptive behavior disorder (DBD).
As might be expected, children and adolescents diag-
nosed with a bipolar disorder and a comorbid psychiatric
diagnosis have a more complicated clinical presentation,
and often have confounding issues that need to be
addressed in treatment.For instance,in those youths with
bipolar disorder and other comorbid conditions,both the
youths and parents reported more family conflict and
lower family cohesion in comparison with youths with
bipolar disorder only.
2 In both the pharmacological and
therapeutic treatment of bipolar disorder,comorbid diag-
noses further complicate the treatment plan by necessi-
tating intervention for multiple psychiatric conditions.
Longitudinal course
Age of onset
Most patients experience their first mood episode
between the ages of 17 and 42 years,with a median age
of onset of 25 years.
26 However,there is evidence to sug-
gest that children do in fact experience the onset of
symptoms of bipolar disorder prior to the age of 17
years.
19,27 In addition, retrospective studies examining
adults with bipolar disorder have reported childhood
onset of symptoms in a substantive number of subjects.
For instance,Perlis et al
28 found when patients recalled
their first mood episode, approximately 65% of adults
experienced onset of symptoms prior to the age of 18.
Moreover, 27.7% of adults reported that they experi-
enced their first mood episode before the age of 13
years.
28
Age of onset appears to impact the course of illness.
29 For
example,in a retrospective study of adults,patients with
childhood or adolescent onset of bipolar symptoms expe-
rienced a greater number of mood episodes and were
more likely to have comorbid psychiatric conditions and
higher rates of rapid cycling.
30 In this same study,adults
with an onset of symptoms at 12 years of age or younger
had the greatest incidence of bipolar and unipolar disor-
ders in their parents.This younger age at onset subgroup
experienced a higher incidence of dysphoric mania,and
a higher prevalence of a lifetime diagnosis of an anxiety
disorder and drug abuse compared with adults who
reported an age of onset of 13 years or greater.
30
Additionally,the age of onset of a parent's bipolar dis-
order has been found to have implications in their off-
spring. For example, Tsuang and Faraone
31 found in
adults that there was a higher risk of developing a mood
disorder if a subject had relatives with an earlier age of
onset of a mood disorder in comparison with subjects
whose relatives had a later age of onset.
Rather than relying on retrospective studies conducted
in adults,researchers have begun to examine the impact
of age of onset in children and adolescents with bipolar
disorder. Youths with early onset of bipolar disorder
prior to the age of 12 have been found to have more first-
degree relatives with a family history of ADHD,conduct
disorder,anxiety disorders,substance dependence,suici-
dal behavior,and suicide attempt and completion in com-
parison with those subjects with a later onset of bipolar
symptoms at 12 years or later.
32 In addition,it has been
reported that children and adolescents with childhood
onset of bipolar disorder were more likely to have suf-
fered from ADHD than those with onset during adoles-
cence.
33
Symptom course 
It appears that after illness onset,children and adoles-
cents with bipolar disorder spend the majority of time
fluctuating between syndromal and subsyndromal mood
episodes,with short periods of euthymia interspersed.
19
For instance, Birmaher et al
34 found that in 263 youths
with a bipolar spectrum disorder,subjects were sympto-
matic during approximately 60% of the 2-year follow-up
period.Furthermore,DelBello et al
35 found that adoles-
cents that had been hospitalized with a BP-I diagnosis,
during the year following their index inpatient stay,spent
a predominant amount of their lives symptomatic.More
specifically, these adolescents spent 84% of the year
experiencing at least subsyndromal symptoms following
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217their hospitalization.In addition,Geller et al
21 reported
that in youths experiencing mania,manic episodes lasted
approximately an average of 80 weeks in duration.
Similarly,in a pediatric cohort with bipolar disorder fol-
lowed for 2 years, only 68% of the cohort experienced
minimal or no symptoms for 8 consecutive weeks after
their index episode.
34 Furthermore,in those subjects that
recovered from their index episode, a median of 78
weeks elapsed from the onset of the presenting mood
episode until symptom remission.
34
The polarity of mood episodes that occur during the
course of bipolarity appear to change as patients with
bipolar disorder age.In adults with bipolar disorder,evi-
dence suggests that depression is the predominant mood
state,with patients spending approximately three times
as much time depressed as manic or hypomanic.
36
However,in children and adolescents,researchers have
reported that hypomanic and manic symptoms dominate,
with depressive episodes being less frequent.
19
Moreover,the mood state of the initial mood episode has
been found to influence time until symptom remission.
For instance, Strober et al
37 reported that adolescent
patients who presented initially in a manic or mixed
episode had a shorter time until mood stabilization in
comparison with patients who experienced a depressive
mood episode initially.Additionally,the longitudinal out-
come appears to be worse in children and adolescents
who have an earlier age of onset of diagnosis,with lower
social economic status, rapid mood fluctuations, psy-
chosis, mixed episodes, more comorbid diagnoses, and
family psychopathology being reported.
38
Evolution of symptoms
There is evidence to suggest that mood and symptoms of
other psychiatric diagnoses in patients may evolve over
time. For instance, mood symptomatology in adults
appears to become more severe with increased number
of mood episodes.In addition,adults appear to experi-
ence fewer periods of euthymia throughout their life-
time.
39 Moreover,with time,mood episodes that occurred
as a result of a psychological stressor may begin to occur
spontaneously without a precipitant.
39
There is also some evidence to suggest that an evolution
of mood symptoms may occur across the diagnostic cat-
egories of the bipolar spectrum disorders over time.For
instance,it appears that patients may experience symp-
toms that meet diagnostic symptom criteria for BP-NOS
and cyclothymia prior to meeting diagnostic symptom
criteria for more syndromal diagnoses of BP-I and BP-
II.
3,40 Birmaher et al
34 found that approximately 20% of
patients initially diagnosed with BP-II converted to BP-
I,and 25% of patients initially diagnosed with BP-NOS
converted to BP-I or BP-II over a mean of 2 years of fol-
low-up monitoring.
ADHD and anxiety symptoms have also been observed
to precede mood symptoms in patients later diagnosed
with bipolar disorder.
24,40,41 It has been suggested that the
high rates of DBDs and ADHD in children of parents
with bipolar disorder may be indicative that DBD and
ADHD symptoms may be prodromal manifestations of
bipolar disorder.
42 By examining children and adolescents
at high risk of developing a bipolar disorder prospec-
tively,this endeavor offers an opportunity to better inves-
tigate early symptoms and biological markers of bipolar
disorders.
High risk studies
It has been suggested that if children are treated soon
after the initial onset of mood symptoms,the develop-
mental impact of the psychiatric illness may be mini-
mized.
39 Furthermore,it appears that bipolar disorders
are highly heritable conditions.
43-45 High rates of affective
disorders in first-degree relatives have been reported in
children with bipolar disorder.For instance,Faedda et al
20
found that 90% of patients with bipolar disorder had a
family history of bipolar disorder. Additionally, it has
been well documented that children and adolescents with
parents diagnosed with a bipolar disorder are at high risk
of developing bipolar disorder themselves.
14,46,47Therefore,
in an attempt to better study the course of bipolar disor-
der and treat patients as soon as possible after symptom
onset,patients who are at risk for developing pediatric
bipolarity are now being examined.
Children of parents with a mood disorder (depression
and/or bipolar disorders) not only have an increased risk
for developing bipolar disorder,but also other psychiatric
disorders.For instance,offspring of parents with a mood
disorder were found to be at risk for depression,anxiety,
ADHD,DBD diagnoses,and more impaired psychoso-
cial functioning.
14,42,47-49 Furthermore,independent of diag-
nosis,children and adolescents of parents with bipolar
disorder have been shown to exhibit higher rates of hos-
tility and irritability in comparison with offspring of par-
ents without a psychiatric disorder.
50
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218Moreover,having only one parent versus both parents
being afflicted with bipolar disorder appears to have
additional implications for the youth's course of illness.
For instance,offspring of two parents with bipolar disor-
der have been found to experience more severe depres-
sion and irritability,lack of mood reactivity,and rejection
sensitivity in comparison with children with only one par-
ent with bipolar disorder.
47Therefore,a patient’s family
history may offer insight into the probability of a child
presenting with or eventually developing bipolar disor-
der.
Biological underpinnings 
Genetic predispositions
Due to the observed high heritability of bipolar disor-
ders,several genetic etiologies of bipolar spectrum dis-
orders have been explored. Multiple genomic regions
have been associated with bipolar disorder and the age
of onset of mood symptoms.
51-54 For instance,regions on
chromosomes 2, 4, 6, 8, 11, 12, 13, 16, 18, 21, 22, and X
have been found to be possibly linked to bipolar disor-
der (see ref 55 for review).
43,55-57 Furthermore, several
functional candidate genes have been identified to be
possibly linked to bipolar disorder including catechol-O-
methyl transferase (COMT),brain-derived neurotropic
factor,tyrosine hydroxylase,D-amino acid oxidase acti-
vator,and neuregulin (see ref 57 for review).
52,57 In addi-
tion,earlier age of onset and increased severity of illness
in subsequent generations of family members have led to
genetic anticipation being hypothesized in bipolar disor-
der (see ref 58 for review).More specifically,it has been
suggested that trinucleotide repeats may be involved in
the genetic predisposition to eventual development of a
bipolar disorder.
58
Structural brain differences 
With advances in imaging techniques,researchers have
begun to investigate whether or not structural differences
in individuals afflicted with bipolar disorder exist when
compared with individuals without a psychiatric illness.
Examinations of neuroanatomical structure differences
of children with bipolar disorder compared with children
without psychiatric disorders have reported conflicting
results.However,it has been found that youths with bipo-
lar disorder may have structural brain differences when
compared with children and adolescents with other psy-
chiatric conditions and youths without psychiatric diag-
noses. These differences include smaller hippocampal
volumes,smaller cerebral volumes (bilateral parietal and
left temporal lobes),and smaller cingulate volumes.
59-62
Recently, in one of the largest samples of youths with
bipolar disorder who underwent a magnetic resonance
imaging (MRI) study,larger right nucleus accumbens of
the basal ganglia were found in this patient population in
comparison with children and adolescents with no psy-
chiatric diagnoses.
63 Additionally, a significant inverse
relationship was found between the right nucleus accum-
bens volume and the number of medications the youth
was currently receiving.
63
Due to the involvement of the amgydalae in emotion
processing,this area of the brain has also been examined.
For instance,Chang et al
64 found that youths with at least
one parent with bipolar disorder and a bipolar disorder
I diagnosis had significantly smaller left and right amgy-
dalar volumes in comparison with healthy offspring of
parents with no psychiatric disorders. In addition,
Blumberg et al
65 found adults and adolescents with bipo-
lar disorder have decreased volumes of the medial tem-
poral lobe structures,especially in the amygdala in com-
parison with subjects without a psychiatric diagnosis.
Moreover,abnormalities in the amygdala-striatal-ventral
prefrontal cortex circuit, which is involved with mood
regulation,have been found in pediatric bipolar disorder
(review in ref 66).
In a review of adult and youth research,subjects with a
recent onset of bipolar disorder were found to have ven-
tricular,white matter,caudate,putamen,amygdala,hip-
pocampus,and subgenual prefrontal cortex volume dif-
ferences (see ref 67 for a review).Furthermore,relatives
of individuals with bipolar disorder showed a reduction
of the subgenual prefrontal cortex in several studies,sug-
gesting a possible neuroanatomical marker for youth at
risk for developing bipolar disorder.
67
There has been some evidence to suggest a possible
change of brain structures over time in adults with bipo-
lar disorder. For instance, over a 4-year period, adults
with bipolar disorder showed a greater decline in hip-
pocampal,fusiform,and cerebellar gray matter density
than adults without a psychiatric disorder.
68 Moreover,in
one longitudinal examination of children prior to and
after the development of bipolar disorder,an increase in
left temporal cortex gray matter volume and decreased
bilateral anterior cingulate cortex gray matter volume
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219was found in comparison with children without a psychi-
atric diagnosis or other psychotic disorder over the
course of 4 to 8 years.
69
Functional neuroimaging 
Differences in areas of brain activation during neurocog-
nitive tasks in patients with bipolar disorder have also
been examined in an attempt to provide insights into the
pathophysiology of this condition. For instance, during
mood episodes, adults with bipolar disorder have been
found to exhibit attentional,memory,and executive func-
tioning impairments during mood episodes,which are sus-
tained to a lesser degree during euthymic periods.
70 It has
been suggested that these continued cognitive impair-
ments during euthymic periods may be a result of under-
lying dysfunctional neurophysiology.
71 More specifically,
using functional MRI (fMRI),euthymic adults with bipo-
lar disorder were found to perform similarly in comple-
tion of an attentional task to healthy controls.However,
the euthymic bipolar group showed greater activation in
the anterior limbic region in compared with healthy con-
trols.
72 Furthermore,Strakowski et al
71 found that in adults
with bipolar disorder who were euthymic,the same pat-
tern of activation in an fMRI during the Stroop interfer-
ence condition was not found in the healthy controls,sug-
gesting possible deficits in impulse control in the patient
group. In comparison with children without a psychiatric
disorder or a first-degree relative with a psychiatric dis-
order, youths with bipolar disorder showed deficits in
engaging striatal structures and the right ventral pre-
frontal cortex using fMRI during unsuccessful motor inhi-
bition.
73 Additionally, Chang et al
74 found that children
and adolescents with bipolar disorder who also had at
least one parent with a bipolar disorder showed increased
activation in the prefrontal areas including the bilateral
anterior cingulate cortex,bilateral caudate,putamen,thal-
amus,dorsolateral prefrontal cortex,and inferior frontal
gyrus while performing cognitive and affective tasks in
comparison with normal controls.This increased cerebral
activation may suggest that children with bipolar disorder
may require increased activation of prefrontal areas of the
brain during periods of euthymia in order to counteract a
hyperactive limbic system.
74 By researchers examining
and characterizing putative biological markers of early
onset bipolar disorder,neuroimaging may eventually be
able to provide clinically salient information early in the
course of illness.
Neuropsychological and social-cognitive factors
Emotional and cognitive processing has been examined in
youth with bipolar disorder.Evidence suggests that chil-
dren and adolescents may misperceive emotions during
social interactions with others.McClure et al
75 found that
sad,happy,and fearful peer facial expressions were misin-
terpreted more often by children with bipolar disorder in
comparison with children with anxiety disorders or sub-
jects with no psychiatric diagnosis.In addition,when view-
ing neutral faces,youth with bipolar disorder perceived
more hostility and experienced more anxiety in compari-
son with youth without a psychiatric disorder.
76 In another
study,children and adolescents with bipolar disorder were
more likely to mistakenly characterize facial emotions
than youths without a psychiatric disorder.
77 Moreover,the
pediatric patients with bipolar disorder were less likely to
choose appropriate responses when presented with inter-
personal situation vignettes when compared with a healthy
control group.
77These emotional and social interpretation
deficits may be due to neural circuitry differences. For
example,Rich et al
78 found that youths with bipolar disor-
der have less functional connectivity in areas that may be
involved in processing facial expressions and emotional
stimuli.These areas include the neural circuitry between
the left amygdala and areas bordering the right posterior
cingulate/precuneus and the right fusiform gyrus/parahip-
pocampal gyrus.
Other studies have found that youths with bipolar disor-
der exhibit less cognitive flexibility in adapting to chang-
ing contingencies in cognitive testing.
77,79 Pavuluri et al
80
found evidence to suggest that activation patterns in brain
regions are different in pediatric bipolar patients in com-
parison with healthy controls when subjects observed
angry and happy faces.These activation differences impli-
cate a disturbance in affect neurocircuitry which may con-
tribute to emotional dysregulation and social cognitive
deficits in youths with bipolar disorder.
80An understand-
ing of these emotional and cognitive processing findings
may have clinical relevance,as they might allow clinicians
to direct a portion of their psychotherapy to address inter-
personal skills and allow educators to modify lesson plans
in order to accommodate the possible cognitive deficits.
Neurochemical differences
Similarly to serotonergic dysfunction observed in depres-
sive conditions, using positron emission tomography
Clinical research
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(PET),a lower serotonin transporter binding potential
(proportional to serotonin transporter number) was
found in adults with bipolar disorder in comparison with
adults with no psychiatric conditions.
81 In addition,using
magnetic resonance spectroscopy (MRS),elevated gray
matter lactate and γ-aminobutyric acid levels have been
found in adults with bipolar disorder in comparison with
adults without a psychiatric diagnosis.
82 Furthermore,
unmedicated youth with bipolar disorder were found to
have significantly lower glutamine levels in the anterior
cingulate cortex compared with subjects with a bipolar
disorder who were currently receiving medications and
subjects without a psychiatric diagnosis,using MRS.
83 By
determining neurochemical differences in youth with
bipolar disorder in comparison with normal controls,
pharmacotherapies could eventually be developed that
could target the neurochemical underpinnings of pedi-
atric bipolarity.
Advances in the treatment of 
bipolarity in children
Psychopharmacology
Unfortunately,historically there have been limited stud-
ies of methodological rigor in children and adolescents
with bipolar disorder.Current recommended treatments
in pediatric bipolar disorder include mood stabilizers and
antipsychotic medications that may be coprescribed with
adjunctive treatments administered for the treatment of
comorbid psychiatric conditions.
84
Acute treatments
There have been a limited number of placebo-controlled
trials that have been performed to investigate efficacy in
the acute treatment of pediatric bipolar illness.
Psychotropics that have been found to be superior to
placebo in the acute treatment of children and adoles-
cents with bipolar disorder presenting with manic or
mixed episodes include olanzapine,
85 risperidone,
86 que-
tiapine,
87 and aripiprazole.
88
Several studies have examined the efficacy of treatment
with divalproex (DVPX) in children with BP-I present-
ing in a mixed or manic episode.Using DVPX extended-
release in a double-blind trial,there was not a significant
improvement of manic symptoms after 4 weeks com-
pared with placebo.
89 However,DVPX was found to be
efficacious in a double-blind study that compared 8
weeks of treatment with DVPX,lithium,and placebo.
90
Furthermore,although the decrease in manic symptoms
in the lithium group did not reach statistical significance
in comparison with the placebo group, there was a
decrease of greater magnitude in manic symptoms in the
lithium group when compared with the placebo.
90
Notably, this trend for lithium to be efficacious may
become more definitively substantiated in subsequent
studies in which higher lithium doses or a larger sample
size is employed.
Failed placebo-controlled trials in the acute treatment of
pediatric bipolar disorder include topiramate
91 and oxcar-
bazepine.
92 It should be noted that the trial examining the
efficacy of topiramate was underpowered due to cessa-
tion of the study after results of the compound in adults
failed to show efficacy. However, when comparing the
mean decrease in total Young Mania Rating Scale
(YMRS) scores over time, statistical significance was
almost reached, with the topiramate group showing a
greater change from baseline scores.Therefore,due to
sample size considerations, whether or not topiramate
truly does or does not have efficacy in this patient popu-
lation remains to be seen.
91
Open-label trials examining the effectiveness and safety
of additional agents and medications mentioned above
when administered to younger cohorts have also shown
positive preliminary results.For example,in youths with
bipolar disorder presenting currently with manic or
mixed states,ziprasidone
93-95 and lithium
96,97 may be effec-
tive in reducing manic symptoms.Moreover,in studies of
patients too young to be included in the aforestated
placebo-controlled trials, olanzapine and risperidone
were found to be effective in children as young as 4 years
of age.
98,99 Open-label treatment with carbamazepine has
also been reported to provide amelioration of manic
symptoms in youths with bipolar disorder.
100
When examining the treatment of youths with bipolar
disorder presenting with depression, open-label trials
have noted that lithium monotherapy,
101 lamotrigine
monotherapy, and lamotrigine adjunctive treatment
102
may be effective in alleviating mood symptoms.Finally,
treatment with open-label clozapine has described as
being effective in youths who were treatment-resis-
tant.
103,104Although ziprasidone,carbamazepine,lithium,
lamotrigine,and clozapine have shown positive effects in
open-label trials,randomized placebo-controlled trials
are needed to produce more definitive conclusions.While some salutary effects have been found in drug
monotherapy studies,it appears that most children and
adolescents do not experience complete symptom remis-
sion with thymoleptic monotherapy. Therefore, in an
attempt to more completely address mood symptoms,
combination pharmacotherapy has been examined in
several clinical trials.In fact,in open-label studies,com-
bination psychotropic treatments appear to be more suc-
cessful than monotherapy treatments in pediatric bipo-
lar disorder.For example,after 6 weeks of treatment with
lithium,DVPX sodium,or carbamazepine,only 38% to
53% of subjects experienced symptom recovery, with
those patients in the carbamazepine group experiencing
the least symptom recovery.
100 However,a proportion of
subjects who did not originally respond to lithium,DVPX
sodium,or carbamazepine monotherapy responded to
combination treatment with two of the abovementioned
mood stabilizers and adjunctive stimulants,antipsychotic
agents,or an antidepressant medication.
105
In addition, DelBello et al
106 found in a double-blind
study that treatment with quetiapine plus valproate was
more effective than treatment with quetiapine monother-
apy in youths with bipolar disorder.Furthermore,com-
bination treatment with both risperidone and lithium or
risperidone and DVPX was found to be effective and
safe in the treatment of children and adolescents with
bipolar I disorder over a 6-month period.
107 Combination
treatment with lithium and DVPX has been found to
ameliorate mood symptoms in several studies.
105,108,109
Finally, positive results were found with combination
treatment with lithium plus either risperidone or a neu-
roleptic.
97,107
Recently,other treatment options have been explored in
pediatric bipolarity.For instance,Wozniak et al
110 found
open-label treatment with omega-3 fatty acids to
improve manic symptoms in youth with bipolar disorder.
Although the results of the abovementioned open-label
trials are promising,randomized,placebo-controlled tri-
als in children and adolescents are needed to provide
more definitive results.Table I includes the dosing and
most frequently reported adverse events in the above-
mentioned studies.
Maintenance treatments
While bipolar disorder is a chronic condition,little atten-
tion has focused on long-term maintenance treatments
in youth.In one of the few maintenance trials,Kafantaris
et al
111 randomized adolescents who had been stabilized
on lithium monotherapy for a minimum of 4 weeks to
either lithium or placebo for 2 subsequent weeks of treat-
ment.Results showed that there was not a significant dif-
ference between treatment groups in rates of symptom
exacerbation.Although this study provides preliminary
insights regarding the continued use of lithium in ado-
lescents with mania,definitive conclusions about lithium
as a maintenance treatment cannot be determined from
these data.Although this was an important trial,method-
ological limitations included a small sample size, the
study’s brevity, and the fact that there was a relatively
abrupt discontinuation of lithium over 3 days in those
subjects randomized to receive placebo in the discontin-
uation phase.In another maintenance double-blind trial,
the efficacy of lithium or DVPX monotherapy for up to
76 weeks in youths who had been stabilized on combi-
nation lithium and DVPX treatment was examined.
112 In
this study,no difference in length of study enrollment was
found between the lithium and DVPX sodium treatment
groups,with both groups ending the study after a mean
of approximately 20 weeks.
112 These results appear to
indicate that once a patient responds to a combination
treatment,discontinuation of one of the agents used in
combination therapy may lead to symptom relapse.
Psychosocial treatments
Favorable results in the treatment of bipolar disorder are
not limited to medication trials. Several psychosocial
treatments have shown positive results in the treatment
of youth with bipolar disorder. For example, dialectal
behavior therapy has been reported to significantly
improve suicidality, self-injurious behavior, emotional
dysregulation,and depressive symptoms after 1 year of
sessions in adolescents diagnosed with a bipolar spec-
trum disorder currently receiving psychotropic medica-
tions.
113 In addition, a 21-session adjunctive family-
focused treatment (FFT) that included psychoeducation,
communication enhancement training,and problem-solv-
ing skills training was found to decrease depressive symp-
toms,maniac symptoms,and behavior problems in ado-
lescents with bipolar disorder.
114 Moreover, individual
family treatment (IFP) and multifamily psychoeducation
groups (MFPG) were developed to provide support,psy-
choeducation, and increase problem-solving and com-
munication skills in families with a child with a mood dis-
order.
115 Both IFP and MFPG have been shown to
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rate mood symptoms,improve the family environment,
and increase mental health service utilization.
115
Additionally, cognitive behavior therapy (CBT) was
found to reduce manic and depressive symptoms in
youth diagnosed with a bipolar disorder spectrum disor-
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Table I. Selected acute trials in the treatment of pediatric bipolar disorder. DVPX, divalproex
Sample size Design Subject ages (y) Dose Most frequently reported 
adverse events
Olanzapine
85 161 Placebo-controlled 13-17 2.5-20 mg/day; Appetite increase, weight increase,
Mean 8.9 mg/day somnolence,and sedation
Risperidone
86 169 Placebo-controlled 10-17 0.5-2.5 mg/day Somnolence, headache, fatigue
3-6 mg/day
Quetiapine
87 277 400 mg vs 600 mg vs placebo10-17 400 mg/day or Somnolence, sedation,
600 mg/day dizziness, headache
Aripiprazole
88 296 10 mg vs 30 mg vs placebo 10-17 10 mg or 3 0 mg Somnolence, extrapyramidal  
symptoms, fatigue
DVPX extended release
89 150 Placebo-controlled 10-17 Starting dose 15 mg/kg/day;  Headache and vomiting
titration to clinical response and/or 
serum level of 80-125 µg/mL
DVPX or lithium
90 153 DVPX, lithium, and placebo 7-17 target DVPX serum level  Not described
85-110 µg/mL; lithium serum 0.8-1.2 mEq/L
Topiramate
91 56 Placebo-controlled 6-17 target dose 400 mg/day Decreased appetite, nausea,  
diarrhea, paresthesia, and somnolence 
in topiramate group
Oxcarbazepine
92 116 Placebo-controlled 7-18 Mean dose 1515 mg/day  Dizziness, nausea,
(maximum dose 900–2400 mg/day) somnolence, diplopia, 
fatigue, and rash
Ziprasidone
95 21 Open-label 6-17 Mean dose: 56.2 (34.4) mg/day Sedation, headache, 
and gastrointestinal problems
Lithium
97 100 Open-label 12-18 Lithium titrated to serum levels  Weight gain, polydipsia,
ranging from 0.6 to 1.2 mEq/L polyuria, headache, and tremor. 
Note: some subjects were receiving 
adjunctive antipsychotic 
medication in this trial
Carbamazepine
100 13 (this was part  Open-label 8-18 Dosages were titrated until  Nausea, sedation,
of a study where  serum levels were reached: rash, and dizziness
subjects received lithium  lithium, 0.8 to 1.2 mEq/L;
or DVPX as well) carbamazepine, 7 to 10 mug/L; 
divalproex sodium, 85 to 110 Ìg/L.
Lamotrigine  20 Open-label 12-17 Target dose: 100 mg/day Headache, fatigue,
monotherapy or as  subjects currently taking DVPX; nausea, and sweating
an adjunctive treatment
102 100- 200 mg/day all other subjects; 
mean final dose 131.6 mg/day
Clozapine
104 10 Open-label 12-17 142.5 +/- 73.6 mg/day  Increased appetite,
(range 75-300 mg/day) sedation, enuresis, sialorrhea
Omega-3 fatty acids
110 20 Open-label 6-17 omega-3 fatty acids 1290 mg- Gastrointestinal problems
4300 mg combined EPA  (constipation, diarrhea,
(eicosapentaenoic acid) and DHA  and upset stomachs),
(docosahexaenoic acid) colds, and headacheder after 12 sessions.
116 CBT supplemented with family-
focused therapy has also shown to ameliorate bipolar
symptoms and increase global functioning scores in
patients with bipolar disorder.
117 Furthermore,the child-
and family-focused CBT program was effective in main-
taining long-term management of mood symptoms over
3 years in youths with bipolar disorder.
118
Interpersonal and social rhythm therapy (IPSRT) is
another treatment that uses some of CBT’s behavioral
interventions to address mood symptoms. However,
IPSRT also focuses both on the youth’s expectations in
their own interpersonal life, and attempts to help the
patient maintain stable social and sleep routines.
119 In
adults,IPSRT has been found to be effective in prolong-
ing the time until patients experience a new mood
episode.
120 Based on these adult data,IPSRT may be an
effective treatment for adolescents with bipolar disor-
der.
119 However,due to difficulties in extrapolating adult
based behavioral interventions in preadolescents,IPSRT
has not been studied in younger children.In short,mul-
tiple psychosocial treatments have been reported to be
effective and are becoming more refined to address
issues specific to youth with bipolar disorder.These treat-
ments may prove to be useful in increasing medication
treatment adherence and providing the additional assis-
tance needed where medication is not able to fully treat
all aspects of pediatric bipolarity.
Future areas of research
Although recent research has broadened the knowledge
about bipolar disorder in youth, there are many unan-
swered questions that remain. More phenomenology
studies may provide insights into whether or not the
comorbid symptoms of additional psychiatric disorders
that are seen in this population are distinct,separate enti-
ties,or simply part of this mood disorder when it presents
during childhood. Furthermore, as children appear to
experience more elevated mood and irritability in com-
parison with adults who report more depressive symp-
toms, future longitudinal examinations may provide
answers to the question of whether or not symptoms of
childhood bipolarity evolve into more adult-like presen-
tations over time.
Examining youths who are at high risk for developing
bipolar disorder,such as offspring of parents with mood
disorders, provides a unique opportunity in carefully
characterizing the evolution of mood symptomatology.
By exploring high-risk cohorts and identifying prodro-
mal symptoms, effective treatments can be 
used earlier in the course of pediatric bipolarity.
121
Furthermore,treating children and adolescents with sub-
syndromal expressions of bipolar disorders soon after
the onset of symptoms may prevent illness progression
to the more severe and prototypic presentations of the
disorder.
Although technological advances have begun to allow
investigators to examine the biological underpinnings of
pediatric bipolarity,larger sample sizes and replication
studies are needed in order to confirm or refute whether
or not the genetic, anatomical, and neurochemical dif-
ferences reported thus far are not chance findings.
Ideally,genetic and neuroimaging methodologies could
eventually be used as a diagnostic tools that could facili-
tate the psychiatric assessment and treatment processes.
Although there is a growing body of evidence that per-
tains to the acute monotherapy pharmacological treat-
ment of pediatric bipolar illness,future studies are also
needed to investigate various combination psychotropic
treatments and adjunctive psychosocial therapies. In
addition, longer term safety and maintenance efficacy
studies with medications are still few in number and are
clearly needed.
In conclusion, with earlier, accurate identification and
diagnosis of bipolar disorders, psychotropic and psy-
chosocial treatment can be initiated earlier in the course
of the illness. It is hoped that with the development of
safe and effective interventions,the probability that the
child suffering from bipolar illness will develop into a
well-adjusted adult with high academic,family,and social
functioning will be better than it is at present. ❏
Dr Findling receives or has received research support, acted as a consultant
and/or served on a speaker's bureau for Abbott, AstraZeneca, Bristol-Myers
Squibb, Cypress Biosciences, Forest, GlaxoSmithKline, Johnson & Johnson,
Lilly, Neuropharm, New River, Novartis, Organon, Otsuka, Pfizer, Sanofi-
Aventis, Sepracore, Shire, Solvay, Supernus Pharmaceuticals, and Wyeth. Dr
Wilson, Christine Demeter, and Lisa Townsend have no financial ties to dis-
close. 
Clinical research
224Child and adolescent bipolar disorder - Demeter et al Dialogues in Clinical Neuroscience - Vol 10 . No.2 . 2008
225
Investigación actual en el trastorno bipolar
en niños y adolescentes
Aunque en la actualidad hay más investigación que
ha incluido niños con trastorno bipolar que en el
pasado, todavía existe mucha controversia alrede-
dor de la validez del diagnóstico. Además persisten
preguntas si acaso las expresiones de bipolaridad
en la niñez constituyen un continuo con las mani-
festaciones de la enfermedad en el adulto. Para
avanzar en el conocimiento actual de los trastornos
bipolares en los niños los investigadores han
comenzado a realizar estudios fenomenológicos,
longitudinales, terapéuticos y de neuroimágenes en
jóvenes que presentan síntomas de enfermedad
bipolar, como también en hijos de padres con tras-
tornos bipolares. A pesar de las diferencias entre
grupos de investigación respecto a cómo está defi-
nido el trastorno bipolar en niños, hay acuerdo en
que la bipolaridad pediátrica es una enfermedad
seria y dañina. Con una intervención precoz
durante el período de tiempo en el cual los jóvenes
presentan síntomas subsindromáticos de bipolari-
dad pediátrica, parece que la progresión de la
enfermedad hacia la manifestación más maligna
del trastorno se puede evitar. Este artículo revisará
el conocimiento actual y lo que todavía falta por
aprender acerca de tópicos clínicamente destacados
que pertenecen al trastorno bipolar en niños y ado-
lescentes.   
Travaux actuels sur les troubles bipolaires de
l’enfant et de l’adolescent
La valeur du diagnostic des troubles bipolaires reste
encore très controversée chez les enfants, bien que
des travaux récents s’y intéressent plus que par le
passé. Un certain nombre de questions demeurent,
comme celle de savoir si la bipolarité dans l’enfance
est en continuité avec les manifestations patholo-
giques de l’âge adulte. Les chercheurs ont entrepris
des études longitudinales phénoménologiques et
thérapeutiques ainsi que des études de neuro-ima-
gerie chez les jeunes qui présentent des symptômes
de troubles bipolaires, mais également chez les des-
cendants de parents bipolaires, afin de faire avan-
cer l’état actuel des connaissances sur les troubles
bipolaires de l’enfant. La bipolarité pédiatrique est
reconnue pour être une pathologie sérieuse et per-
nicieuse, quelles que soient les différences de défi-
nition entre les équipes de recherche. Si les jeunes
sont traités précocement, dès l’apparition des symp-
tômes subsyndromaux de la maladie bipolaire
pédiatrique, la progression vers les formes les plus
sévères pourrait être évitée. Cet article passe en
revue les connaissances actuelles et ce qu’il reste à
apprendre à propos de sujets cliniquement perti-
nents liés aux troubles bipolaires chez l’enfant et
l’adolescent. 
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